$13.060
-0.246 (-1.88%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
MPLT 相似图表分析预测
Alphio's MPLT stock price prediction model matches the current MapLight Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.00 (-0.46%). The 1-week path is $12.97 (-0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 MapLight Therapeutics Inc 股票吗?
MapLight Therapeutics, Inc. is a good buy right now due to its current price of $12.6, which is significantly below the recent analyst price target of $25 from Craig-Hallum. The stock has shown a strong recent performance with a 5-day change of +12.40%, indicating positive momentum. However, investors should be cautious of the risk posed by the negative sentiment surrounding the Phase 2 trial results, which have led to downgrades and a projected EPS of -1.32 for the last earnings report, reflecting ongoing financial challenges.
MPLT 股价于 Wednesday 收于 $13.06,此前下跌 -1.88%
MapLight Therapeutics Inc (MPLT) last closed at $13.06, losing -1.88%. These facts feed the 1-day and 1-week MPLT price prediction above.
预测驱动因素
MapLight Therapeutics Inc(MPLT)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 MPLT 最接近的股票,按相似度排序。
MPLT 季节性分析
Historically the probability of a positive September return for MPLT is 0.00%. March offers the highest probability of a positive month at 100.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。